2,143 recalls tagged with “cpsc regulated”.
Updated MRI safety testing demonstrates higher RF-induced temperature increases under certain MRI conditions than previously reflected in the Instructions for Use (IFU).
Updated MRI safety testing demonstrates higher RF-induced temperature increases under certain MRI conditions than previously reflected in the Instructions for Use (IFU).
Updated MRI safety testing demonstrates higher RF-induced temperature increases under certain MRI conditions than previously reflected in the Instructions for Use (IFU).
Updated MRI safety testing demonstrates higher RF-induced temperature increases under certain MRI conditions than previously reflected in the Instructions for Use (IFU).
The firm has identified that the battery runtime and cycle specifications contained in the devices Instructions for Use (IFU) need to be updated.
The firm has identified that the battery runtime and cycle specifications contained in the devices Instructions for Use (IFU) need to be updated.
Product may contain foreign material.
Mikario Trading recalled 5,000 convertible baby gyms on January 22, 2026, due to a suffocation risk. The baby gyms violate safety standards for infant support cushions. Consumers must stop using the product immediately and seek a refund.
Yetonamr recalled Pull String Teething Toys on January 22, 2026, due to choking risks. The toys violate safety standards with silicone strings that can obstruct breathing. Consumers must stop using the toys immediately and seek refunds.
Topkay recalled torch lighters on January 22, 2026, due to serious fire and burn hazards. The lighters lack required child-resistant features, posing risks to consumers. The recall affects lighters sold on Amazon by Xiyude.
Gagaku recalled ice cream shop toy playsets on January 22, 2026, due to a magnet ingestion hazard. The toys can pose serious injury or death risks if magnets detach and are swallowed. Consumers should stop using the toys and seek a refund immediately.
Thrasio recalled Angry Orange Enzyme Stain Removers on January 22, 2026. The products may contain the bacteria Pseudomonas aeruginosa, posing serious health risks. Consumers should stop using the product and seek a refund immediately.
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Due to pediatric defibrillator electrode delamination
Unichem Pharmaceuticals recalled 60,000 bottles of Doxazosin Tablets on January 21, 2026. The tablets were imprinted with the wrong ID, posing a serious risk to consumers. Healthcare providers and users should stop using the product immediately.